Connection
Robert Scheinman to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications Robert Scheinman has written about Drug Screening Assays, Antitumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.010 |
|
|
|
-
Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL). Anticancer Res. 2000 Nov-Dec; 20(6B):4243-55.
Score: 0.010